newsfilter
← Latest News
GlobeNewswire·

Prelude Therapeutics Announces $25 Million Private Placement

WILMINGTON, Del., Dec. 11, 2023 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (NASDAQ:PRLD) ("Prelude" or the "Company"), a clinical-stage precision oncology company, today announced a private placement that